RichardGGowerMD

PubMed

• 43 citations
  Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
  Marc A. Riedl, Anette Bygum, William R. Lumry, Markus Magerl, J.A. Bernstein
  The Journal of Allergy and Clinical Immunology. in Practice. 2016-09-01
• 23 citations
  Current Medical Management of Hereditary Angioedema: Follow-up Survey of US Physicians
  Marc A. Riedl, Aleena Banerji, Richard G. Gower
  The Journal of Allergy and Clinical Immunology. in Practice. 2015-03-01
• 87 citations
  Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asth...
  Tim W Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis
  The Lancet. Respiratory Medicine. 2021-03-01

Journal Articles

• Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations  
  Gower, et al., Allergy and Asthma Proceedings, 5/1/2012
• Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1inhibitor deficiency: consensus report of an International Working Group  
  Cicardi et al., Allergy, 1/1/2012
• “Hereditary Angioedema: Implications of Treating a Rare Disease”. Letter to the Editor.  
  Kalfus et al., Annals of Allergy, 1/1/2012
• Hereditary Angioedema Caused by C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies  
  Gower, et al., World Allergy Organization Journal, 2/1/2011
• Clinical Presentation, Diagnosis, and Treatment of Hereditary Angioedema: An Overview  
  Gower, et al., Clinical Cornerstone. Focus on Angioedema, 1/1/2011
• Current Medical Management of Hereditary Angioedema: Results From a Large Survey of U.S. Physicians  
  Riedl et al., Annals of Allergy, Asthma & Immunology, 1/1/2011
• Improving Outcomes in Hereditary Angioedema: Clinical cases and Expert Opinion  
  ACAAI CME Newsletter, 1/1/2011
• Sublingual Immunotherapy: World Allergy Organization Position Paper 2009  
  Canonica GW, Bousquet J, Casale T, Lockey R, Baena-Cagnani C et al., World Allergy Organization Journal, 1/1/2009
• When is prophylaxis for hereditary angioedema necessary?  
  Craig et.al., Annals of Allergy, 1/1/2009
• Eradication of common pathogens at Days 2, 3, and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis  
  BMC Ear, Nose and Throat Journal, 1/1/2006
• Frozen Tears  
  John Strimas, M.D., Annals of Allergy, 5/1/2005
• Insurance Coverage for H1 Antihistamines: Implications for Quality Health Care and Public Safety  
  Position Statement of the AAAAI, ACAAI, and JCAAI, 11/18/2002
• Inhaled Mometasone Furoate Reduces Oral Prednisone Requirements While Improving Respiratory Function and Health-Related Quality of Life in Patients With Severe Persist...  
  Journal of Allergy and Clinical Immunology, 11/1/2000
• Asmanex Twisthaler: A New Inhaled Corticosteroid for the Treatment of Asthma  
  Key Pharmaceuticals, 8/25/1999
• Hypothalamic-Pituitary-Adrenal Axis Function During Treatment of Pediatric and Adolescent Asthma with Beclomethasone Dipropionate or Fluticasone Propionate  
  Advances in Therapy, 3/1/1997
• Join now to see all

Books/Book Chapters

• Clinical and Experimental Pheochromocytoma 
  Chapter: Cerebral Vasculitis Associated with Pheochromocytoma 
  Page 335 - 339Richard G. Gower, M.D.Editors: Dr. William M.Manger.Blackwell ScienceEdition seco,1996

Abstracts/Posters

• Management Plan for Patients with Hereditary Angioedema
  Gower RG, ACAAI Annual Meeting, 2011; WSAAI Annual Meeting, 2012; EAACI Annual Congress, 2012, Boston, MA, 2011; Kauai, HI, 2012; Geneva, Switzerland, 2012, 6/1/2012
• Management Plan for Patients with Hereditary Angioedema
  Gower, et al., ACAAI meeting, 2011; WSAAI meeting , 2012, Boston, MA, 2011; Kauai, HI, 2012, 1/1/2012
• A multi-site study evaluating patient perceptions of Olapatadine 0.2% in patients with allergic conjunctivitis
  WSAAI, 1/1/2008
• Once-daily ciclesonide is effective and well-tolerated in the treatment of Adult and Adolescent patients with mild-to-moderate Asthma
  AAAAI, 3/1/2005
• Reduction in Oral Corticosteriod Use with Mometasone Furoate Dry Powder Inhaler Improves Health-Related Quality of Life in Patients With Severe Persistent Asthma
  Jordana Schmier, Nancy Kline Leidy, and Richard G. Gower, Jnl. Of Asthma, European Respiratory Society, 2002; WSAAI Kona, 2003, Stockholm, Sweden, 2002; Kona, HI, 2003, 1/1/2003
• Cerebral Vasculitis Associated with Pheochromocytoma
  Richard G. Gower, M.D., Multiple locations, 1992, 1993, 1994, 1/23/1994
• Small Vessel Vasculitis Associated with Hepatitis B Surface Antigen
  Richard G. Gower, William F. Sausker, Peter F. Kohler, E. George Thorne, Rawle M. McIntosh, Journal of Allergy/Clinical Immunology, American Congress of Allergy, 1977, New York City, NY, 3/1/1977
• Leukocytoclastic Vasculitis - A Sequential Study of Immunoreactants and Cellular Reactants After Histamine Injection
  Richard G. Gower, W. Mitchell Sams, E. George Thorne, Peter F. Kohler, and Henry N. Claman, Journal of Investigative Dermatology, American Academy of Dermatology, 1976, Chicago, IL, 1/1/1977
• Ultraviolet-induced Changes in Residual Thermoluminescence from Gamma-irradiated Lithium Fluoride
  Richard G. Gower, William R. Hendee, and Geoffrey S. Ibbott, Health Physics, Multiple locations, 1969, 1/1/1969
• Join now to see all

Lectures

• HAE Update: Determining Optimal Patient Specific Therapy 
  West Palm Beach, FL - 6/1/2012
• The Evolving Science of Asthma 
  Great Falls, MT - 4/1/2012
• CVID: A Case Study 
  Kauai, HI - 1/1/2012
• HAE in Special Populations A Focus on Women 
  Boston, MA - 11/1/2011
• Hereditary Angioedema- New Trends in Managing a Complex Disease 
  Beijing, PRC - 9/1/2011
• Advances in hereditary Angioedema: From Prophylaxis to acute therapy 
  Coeur D’Alene, ID - 7/1/2011
• A clinician’s view on the role of nanofiltered C1 inhibitor (human) 
  Istanbul, Turkey - 6/1/2011
• Improving Outcomes in Hereditary Angioedema Clinical Cases and Expert Opinion: Individualization of Therapy 
  Phoenix, AZ - 11/1/2010
• US Experience with C1 esterase inhibitor 
  London, England - 6/1/2010
• State of the College 
  Multiple locations, 2008-2009 - 11/1/2009
• Improving the Quality of Life in patients with Severe Persistent Asthma 
  Multiple locations, 2009 - 11/1/2009
• How GARD is integrating the WHO Noncommunicable Diseases action plan and NCDnet: (Noncommunicable Disease Network) 
  1/1/2009
• Rhinitis Practice Parameter Update 
  Jerusalem, Israel - 12/5/2008
• Asthma 2008: The New NHLBI Guidelines 
  Spokane, WA - 2/1/2008
• Angioedema and Urticaria 
  Hong Kong and Xian, China - 12/9/2007
• Will Pay for Performance Improve Allergy and Asthma Care? 
  Dallas, TX - 11/13/2007
• Association of Allergic Rhinitis and Asthma: Chronic Allergic Respiratory Syndrome 
  Buenos Aires, Argentina - 6/6/2006
• Management of Respiratory Infections 
  Multiple locations, 2004-2005 - 12/20/2005
• Asthma/Allergy Link 
  Honolulu, HI, 1998; Anchorage, AK, 1998; Portland, OR, 2005 - 12/14/2005
• Anti-IgE Therapy: A Novel Treatment for Asthma 
  Multiple locations, 2001, 2003-2005 - 12/7/2005
• Mechanisms of Allergy and Asthma 
  Gleneden Beach, OR - 9/10/2005
• Allergic Rhinitis: Looking Beyond Quality of Life 
  Portland, OR, 2005; Milwaukee, WI, 2005 - 6/3/2005
• Management of Allergic Rhinitis 
  Coeur d'Alene, ID, 1998; Seattle, WA, 2001; Coeur d'Alene, ID, 2005 - 5/18/2005
• Allergies, Asthma, and Allergy Testing 
  San Francisco, CA - 4/14/2005
• The Role of Leukotriene Modifiers in the Treatment of Allergic Rhinitis and Asthma 
  Multiple locations, 2004-2005 - 3/29/2005
• Join now to see all

Other

• An Update of the Treatment of Allergic Rhinitis 
  National Teleconference
  5/8/2004
• Patient Preference in Allergic Rhinitis 
  National Teleconference
  10/24/2002
• Oral Inhaled Corticosteriod Therapy as the Cornerstone of Treatment in Persistent Asthma 
  Teleconference presentations to western regional physicians
  11/4/1997
• Significance and Treatment of Allergic Rhinitis 
  Teleconference for regional physicians
  9/25/1997
• Delivery Devices and Oral Inhaled Corticosteroids: Clinical Update in Asthma Management 
  Teleconference presentations to physicians and staff
  12/18/1996
• Join now to see all